|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen L, Zuo Y, Zhu L, Zhang Y, Li S, Ma F,
Han Y, Song H and Xue Y: Peripheral venous blood
neutrophil-to-lymphocyte ratio predicts survival in patients with
advanced gastric cancer treated with neoadjuvant chemotherapy. Onco
Targets Ther. 10:2569–2580. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen S and Birk DE: The regulatory roles
of small leucine-rich proteoglycans in extracellular assembly. FEBS
J. 280:2120–2137. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Moreth K, Iozzo RV and Schaefer L: Small
leucine-rich proteoglycans orchestrate receptor crosstalk during
inflammation. Cell Cycle. 11:2084–2091. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Baghy K, Dezso K, László V, Fullár A,
Péterfia B, Paku S, Nagy P, Schaff Z, Iozzo RV and Kovalszky I:
Ablation of the decorin gene enhances experimental hepatic fibrosis
and impairs hepatic healing in mice. Lab Invest. 91:439–451. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schaefer L and Iozzo RV: Small
leucine-rich proteoglycans, at the crossroad of cancer growth and
inflammation. Curr Opin Genet Dev. 22:56–57. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
de Wit M, Carvalho B, Delis-van Diemen PM,
van Alphen C, Beliën JAM, Meijer GA and Fijneman RJA: Lumican and
versican protein expression are associated with colorectal
adenoma-to-carcinoma progression. PLoS One. 12:e01747682017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kalamajski S and Oldberg A: The role of
small leucine-rich proteoglycans in collagen fibrillogenesis.
Matrix Biol. 29:248–p253. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nikitovic D, Papoutsidakis A, Karamanos NK
and Tzanakakis GN: Lumican affects tumor cell functions, tumor-ECM
interactions, angiogenesis and inflammatory response. Matrix Biol.
35:206–214. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Appunni S, Anand V, Khandelwal M, Seth A,
Mathur S and Sharma A: Altered expression of small leucine-rich
proteoglycans (Decorin, Biglycan and Lumican): Plausible diagnostic
marker in urothelial carcinoma of bladder. Tumour Biol.
39:10104283176991122017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xiao LL and Xiao XY: Histological and
molecular classification of gastric cancer and personalized
therapy. WCJD. 23:4141–4149. 2015. View Article : Google Scholar
|
|
14
|
Liu JW, Liu HL and Zhang T: Research
progress of molecular type of gastric cancer. Chin J Clin.
8:4444–4448. 2014.
|
|
15
|
Guggenheim JA, Zayats T, Hammond C and
Young TL: Lumican and muscarinic acetylcholine receptor 1 gene
polymorphisms associated with high myopia. Eye (Lond).
24:1411–1412. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Matsuda Y, Yamamoto T, Kudo M, Kawahara K,
Kawamoto M, Nakajima Y, Koizumi K, Nakazawa N, Ishiwata T and Naito
Z: Expression and roles of lumican in lung adenocarcinoma and
squamous cell carcinoma. Int J Oncol. 33:1177–1185. 2008.PubMed/NCBI
|
|
17
|
Hayashi Y, Call MK, Chikama T, Liu H,
Carlson EC, Sun Y, Pearlman E, Funderburgh JL, Babcock G, Liu CY,
et al: Lumican is required for neutrophil extravasation following
corneal injury and wound healing. J Cell Sci. 123:2987–2995. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kalamajski S and Oldberg A: Homologous
sequence in lumican and fibromodulin leucine-rich repeat 5–7
competes for collagen binding. J Biol Chem. 284:534–539. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nikitovic D, Katonis P, Tsatsakis A,
Karamanos NK and Tzanakakis GN: Lumican, a small leucine-rich
proteoglycan. IUBMB Life. 60:818–823. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Seomun Y and Joo CK: Lumican induces human
corneal epithelial cell migration and integrin expression via ERK
1/2 signaling. Biochem Biophys Res Commun. 372:221–225. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nikitovic D, Berdiaki A, Zafiropoulos A,
Katonis P, Tsatsakis A, Karamanos NK and Tzanakakis GN: Lumican
expression is positively correlated with the differentiation and
negatively with the growth of human osteosarcoma cells. FEBS J.
275:350–361. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chakravarti S, Stallings RL, SundarRaj N,
Cornuet PK and Hassell JR: Primary structure of human Lumican
(keratan sulfate proteoglycan) and localization of the gene (LUM)
to chromosome 12q21.3-q22. Genomics. 27:481–488. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kafienah W, Cheung FL, Sims T, Martin I,
Miot S, Von Ruhland C, Roughley PJ and Hollander AP: Lumican
inhibits collagen deposition in tissue engineered cartilage. Matrix
Biol. 27:526–534. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sharma B, Ramus MD, Kirkwood CT, Sperry
EE, Chu PH, Kao WW and Albig AR: lumican exhibits anti-angiogenic
activity in a context specific manner. Cancer Microenviron.
6:263–271. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kashyap MK, Marimuthu A, Peri S, Kumar GS,
Jacob HK, Prasad TS, Mahmood R, Kumar KV, Kumar MV, Meltzer SJ, et
al: Overexpression of periostin and lumican in esophageal squamous
cell carcinoma. Cancers. 2:133–142. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Colak D, Chishti MA, Al-Bakheet AB,
Al-Qahtani A, Shoukri MM, Goyns MH, Ozand PT, Quackenbush J, Park
BH and Kaya N: Integrative and comparative genomics analysis of
early hepatocellular carcinoma differentiated from liver
regeneration in young and old. Mol Cancer. 9:1462010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li X, Truty MA, Kang Y, Chopin-Laly X,
Zhang R, Roife D, Chatterjee D, Lin E, Thomas RM, Wang H, et al:
Extracellular lumican inhibits pancreatic cancer cell growth and is
associated with prolonged survival after surgery. Clin Cancer Res.
20:6529–6540. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li X, Roife D, Kang Y, Dai B, Pratt M and
Fleming JB: Extracellular lumican augments cytotoxicity of
chemotherapy in pancreatic ductal adenocarcinoma cells via
autophagy inhibition. Oncogene. 35:4881–4890. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Eshchenko TY, Rykova VI, Chernakov AE,
Sidorov SV and Grigorieva EV: Expression of different proteoglycans
in human breast tumors. Biochemistry (Moscow). 72:1016–1020. 2007.
View Article : Google Scholar
|
|
30
|
Kang Y, Roife D, Lee Y, Lv H, Suzuki R,
Ling J, Perez Rios MV, Li X, Dai B, Pratt M, et al: Transforming
Growth Factor-β limits secretion of lumican by activated stellate
cells within primary pancreatic adenocarcinoma tumors. Clin Cancer
Res. 22:4934–4946. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Seya T, Tanaka N, Shinji S, Yokoi K,
Koizumi M, Teranishi N, Yamashita K, Tajiri T, Ishiwata T and Naito
Z: Lumican expression in advanced colorectal cancer with nodal
metastasis correlates with poor prognosis. Oncol Rep. 16:1225–1230.
2006.PubMed/NCBI
|
|
32
|
Radwanska A, Litwin M, Nowak D, Baczynska
D, Wegrowski Y, Maquart FX and Malicka-Blaszkiewicz M:
Overexpression of lumican affects the migration of human colon
cancer cells through up-regulation of gelsolin and filamentous
actin reorganization. Exp Cell Res. 318:2312–2323. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yamamoto T, Matsuda Y, Kawahara K,
Ishiwata T and Naito Z: Secreted 70 kDa lumican stimulates growth
and inhibits invasion of human pancreatic cancer. Cancer Lett.
320:31–39. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
de Wit M, Belt EJ, Delis-van Diemen PM,
Carvalho B, Coupé VM, Stockmann HB, Bril H, Beliën JA, Fijneman RJ
and Meijer GA: Lumican and versican are associated with good
outcome in stage II and III colon cancer. Ann Surg Oncol. 20 Suppl
3:S348–S359. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nikitovic D, Chalkiadaki G, Berdiaki A,
Aggelidakis J, Katonis P, Karamanos NK and Tzanakakis GN: Lumican
regulates osteosarcoma cell adhesion by modulating TGFβ2 activity.
Int J Biochem Cell Biol. 43:928–935. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Naito Z: Role of the small leucine-rich
proteoglycan (SLRP) family in pathological lesions and cancer cell
growth. J Nippon Med Sch. 72:137–145. 2005. View Article : Google Scholar : PubMed/NCBI
|
